Blog
Thursday, January 25, 2024
This is an excerpt of Chapter 11 from our new book Transforming the Business of Government: Insights on Resiliency, Innovation, and Performance.
Wednesday, January 24, 2024
Modern U.S. regulatory practices have their roots in the first regulatory agencies established in the late 19th century, in the Administrative Procedure Act of 1946, and in the regulatory reforms of the 1970s and 1980s.
Tuesday, January 23, 2024
This is an excerpt of Chapter 10 from our new book Transforming the Business of Government: Insights on Resiliency, Innovation, and Performance.
by Dan Chenok
Monday, January 22, 2024
The IBM Center recently hosted many government leaders and stakeholders for our 25th Anniversary celebration and release of the new book, Transforming the Business of Government: Insights on Resiliency, Innovation, and Performance.
Friday, January 19, 2024
Articles & insights in public management & leadership for the week ending January 19, 2024
by Paula Ganga, PhD
Thursday, January 18, 2024
This is an excerpt of Chapter 9 from our new book Transforming the Business of Government: Insights on Resiliency, Innovation, and Performance.
Tuesday, January 16, 2024
This chapter proposes two ways that public procurement processes can improve customer experience (CX) through artificial intelligence (AI) and presents seven design principles to guide the procurement of AI tools in the public sector.
Thursday, January 11, 2024
This is an excerpt of Chapter 7 from our new book Transforming the Business of Government: Insights on Resiliency, Innovation, and Performance.
Thursday, January 11, 2024
The Office of Management and Budget released a new set of performance-related promises by federal agencies in advance of the New Year. It also refreshed its one-stop performance-tracking website, providing users new tools to interactively explore what the federal government has committed to achieve, and its progress towards those commitments.
by Dan Chenok
Wednesday, January 10, 2024
A new report analyzes effective practices and makes recommendations for scientific decision-making in government, based on the FDA experience.